Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregons state-regulated modelmedRxiv · 2026-08-19A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocinArchives of Toxicology · 2026-08-01Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse modelsbioRxiv · 2026-07-28Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.Molecular neurobiology · 2026-07-28Uncovering the spatiotemporal structure of neural avalanches through optimal transport and dynamic time warpingbioRxiv · 2026-07-16Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-12Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01Human brain changes after first psilocybin useNature Communications · 2026-05-05Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.Journal of psychopharmacology (Oxford, England) · 2026-05-01“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22Psychedelic medicine: mechanisms, evidence, and translation to practice.BMJ (Clinical research ed.) · 2026-02-23Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01Psychedelics in psychiatric treatment: a literature reviewQuality in Sport · 2026-01-26From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.Translational behavioral medicine · 2026-01-07Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication StudyResearch Square · 2025-09-25Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted TherapyExhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University) · 2025-04-23Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-06Practical considerations in the establishment of psychedelic research programs.Psychopharmacology · 2025-01-01Legal and Ethics Concerns of Psilocybin as Medicine.The journal of the American Academy of Psychiatry and the Law · 2024-12-12Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological PotentialsInternational Journal for Research in Applied Science and Engineering Technology · 2024-11-17The role of psilocybin in depressive disorders.Current medical research and opinion · 2024-10-01Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithiumbioRxiv · 2024-08-09Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-13Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical studyPsyArXiv · 2024-01-11Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Psychological medicine · 2024-01-01Effects of hallucinogenic drugs on the human heart.Frontiers in pharmacology · 2024-01-01A narrative exploration of psilocybin's potential in mental health.Frontiers in psychiatry · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depressionResearch Square · 2023-12-28Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.Psychological medicine · 2023-12-01Psilocybin (Magic Mushrooms)GFNPSS-International Journal of Multidisciplinary Research · 2023-06-02Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive DisorderEuropean psychiatry: the journal of the Association of European Psychiatrists · 2022-09-01Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.Journal of psychopharmacology (Oxford, England) · 2022-07-01Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific reports · 2022-06-22Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific reports · 2022-04-07A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.The international journal of neuropsychopharmacology · 2021-09-21Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01Systematic Error for Extraction of Controlled Substances from Plant/Fungal Materials.Journal of chromatographic science · 2020-10-26Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.CNS drugs · 2020-09-01Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017Drug Science Policy and Law · 2020-01-01P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-12-01Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography.Journal of chromatographic science · 2019-03-01Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.Journal of affective disorders · 2018-04-01Psychedelic Drugs in Biomedicine.Trends in pharmacological sciences · 2017-11-01Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia · 2015-06-015HT2a Receptors - a New Target for Depression?European Psychiatry · 2015-03-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of psychopharmacology (Oxford, England) · 2013-09-01Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.Planta medica · 2006-06-01Khat and mushrooms associated with psychosis.The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry · 2004-01-01[Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide].Comptes rendus des seances de la Societe de biologie et de ses filiales · 1959-01-01